You are here

OPENCELL TECHNOLOGIES, INC.

Company Information
Address
4320 Forest Park Ave
SAINT LOUIS, MO 63108-2979
United States



Information

UEI: Q6HJH3BNJH96

# of Employees: 3


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics

    Amount: $1,760,111.00

    Abstract CAR-T therapy is a rapidly emerging therapy for the treatment of cancer, with two companies receiving FDA approval for their first CAR-T therapies in 2017. These therapies use immune cells ca ...

    SBIRPhase II2021Department of Health and Human Services National Institutes of Health
  2. Developing a Platform for Multiplexed Large Payload Delivery

    Amount: $298,853.00

    Abstract BackgroundNew approaches to therapeutic development using cellular engineering are rapidly emerging and evolvingApplications such asbut not limited tochimeric antigen receptorCART cellsregene ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  3. Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics

    Amount: $247,405.00

    Abstract SignificanceIntracellular delivery of nucleic acids to immune cells is an important component of many current and anticipated cellular therapiesincluding chimeric antigen receptor T CellCAR T ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  4. MIST System for Simultaneous Parallel Intracellular Delivery & Transfection

    Amount: $899,488.00

    DESCRIPTION provided by applicant Alternative nanomaterial and gene transfer solutions are needed to access the potential held in intracellular imaging biopharmaceuticals gene t ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  5. STTR Phase I: Polymer electrosonic actuation microarray: Low-cost tool for transfection of biological cells

    Amount: $225,000.00

    This Small Business Technology Transfer (STTR) Phase I project will prove the technical and commercial feasibility of a single-use polymer microarray for electromechanical transfection of biological c ...

    STTRPhase I2013National Science Foundation
  6. Electrosonic Actuation Microarray: High-Throughput Tool for Transfection of Diffi

    Amount: $1,008,001.00

    DESCRIPTION (provided by applicant): The ability to introduce drugs, genes, nucleic acids, and/or imaging agents into living cells is critical to drug design and delivery, as well as many cell biology ...

    SBIRPhase II2011Department of Health and Human Services National Institutes of Health
  7. Multichannel Electrosonic Actuation Microarray for Cell-Based Screening

    Amount: $158,708.00

    DESCRIPTION (provided by applicant): High-throughput, parallel delivery and transfection of biologically relevant material into cells remains a difficult task. The proposed work addresses this issue t ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  8. Electrosonic Ejector Microarray for Development of Cancer Therapies

    Amount: $120,586.00

    DESCRIPTION (provided by applicant): Despite decades of research focused mainly on gene transfection, effective intracellular delivery of biologically relevant material remains a difficult task, inhi ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government